Mednet Logo
HomeQuestion

Do you modify the duration of adjuvant therapy for patients with colon cancer who have undergone metastectomy and primary tumor resection?

1
1 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center

For de novo oligometastatic colon cancer that is amenable to a potentially curative approach, I aim for 6 months of perioperative chemotherapy with fluoropyrimidine and oxaliplatin. Since irinotecan, anti-EGFR monoclonal antibodies, and bevacizumab do not treat micrometastatic disease effectively, t...

Register or Sign In to see full answer

Do you modify the duration of adjuvant therapy for patients with colon cancer who have undergone metastectomy and primary tumor resection? | Mednet